Tirzepatide vs Liraglutide: Which Weight Loss Medication is Best?

Key Point 1 Tirzepatide and liraglutide are both prescription medications used for weight loss and type 2 diabetes management.

Key Point 2 Tirzepatide works on both GLP-1 and GIP receptors, potentially leading to greater weight loss compared to liraglutide, which only targets GLP-1 receptors.

Key Point 3 Both medications are administered via injection, but tirzepatide is injected weekly, while liraglutide is injected daily.

Key Point 4 Common side effects include nausea, diarrhea, and vomiting, but individual experiences may vary. Consulting with a doctor is essential to determine the best option.

Understanding Tirzepatide and Liraglutide

Tirzepatide (brand name Mounjaro) and liraglutide (brand name Saxenda) are both injectable medications approved for weight loss and the treatment of type 2 diabetes. They belong to a class of drugs known as incretin mimetics, which mimic the effects of natural hormones in the body to regulate blood sugar and appetite. However, they differ in their mechanisms of action and overall efficacy.

Hi Doctor AI provides telemedicine consultations. All treatments are prescribed by EU-licensed doctors after reviewing your medical history. We do not sell or ship medications—prescriptions can be used at any licensed pharmacy in the EU.

How Tirzepatide and Liraglutide Work

Liraglutide is a GLP-1 receptor agonist. GLP-1 (glucagon-like peptide-1) is a hormone that stimulates insulin release, inhibits glucagon secretion, slows gastric emptying, and increases satiety. By mimicking GLP-1, liraglutide helps to lower blood sugar levels and reduce appetite, leading to weight loss.

Tirzepatide, on the other hand, is a dual GLP-1 and GIP receptor agonist. GIP (glucose-dependent insulinotropic polypeptide) is another hormone that, like GLP-1, stimulates insulin release. By acting on both receptors, tirzepatide may offer additional benefits in terms of blood sugar control and weight loss. Studies suggest that the combined action on both receptors leads to a more pronounced effect on appetite regulation and energy expenditure.

Efficacy and Weight Loss Results

Clinical trials have demonstrated that both tirzepatide and liraglutide are effective for weight loss. However, tirzepatide has shown more significant weight loss results compared to liraglutide.

In studies, tirzepatide has been shown to produce an average weight loss of up to 22.5% of initial body weight over 72 weeks, depending on the dosage. Liraglutide, in comparison, typically results in an average weight loss of around 8% after 56 weeks. The greater weight loss observed with tirzepatide is attributed to its dual mechanism of action on both GLP-1 and GIP receptors.

The timeline for weight loss varies among individuals, but generally, noticeable changes can be observed within the first few months of treatment. Consistent adherence to the prescribed dosage and a healthy lifestyle, including diet and exercise, are crucial for achieving optimal results.

Administration and Dosage

Both tirzepatide and liraglutide are administered via subcutaneous injection. However, there is a key difference in the frequency of injections. Tirzepatide is injected once weekly, while liraglutide is injected once daily. This difference in administration frequency may influence patient preference and adherence to treatment.

Tirzepatide is available in dosages ranging from 2.5mg to 15mg, while liraglutide dosages range from 0.6mg to 3mg. The appropriate dosage is determined by a healthcare professional based on individual needs and response to treatment. It is common to start with a low dose and gradually increase it to minimize potential side effects.

Safety and Side Effects

Like all medications, tirzepatide and liraglutide can cause side effects. Common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain. These side effects are typically mild to moderate in severity and tend to improve over time as the body adjusts to the medication.

More serious, but less common, side effects may include pancreatitis, gallbladder problems, and kidney problems. It is important to be aware of these potential risks and to report any unusual symptoms to a healthcare professional promptly. Tirzepatide and liraglutide may not be suitable for everyone, especially those with a history of certain medical conditions, such as pancreatitis or thyroid cancer.

How Hi Doctor AI Helps

Hi Doctor AI offers a convenient and discreet way to access medical consultations for weight management. Our EU-licensed doctors can assess your medical history and determine if tirzepatide or liraglutide is an appropriate treatment option for you. We provide a fully online consultation process, eliminating the need for in-person visits. If deemed suitable, you'll receive a valid EU prescription in under 24 hours, which you can use at any licensed pharmacy in the EU. With Hi Doctor AI, you can take control of your weight loss journey from the comfort of your own home.

Ready to Get Started?

Ready to start your weight loss journey? Get your online consultation with Hi Doctor AI—EU-licensed doctors, 45€ consultation fee.